Ambu A/S Ambu A/S

Ambu A/S

AMBU-B

Classifica tra le azioni #5082
Established in 1937 and headquartered in Ballerup, Denmark, Ambu A/S is a... Established in 1937 and headquartered in Ballerup, Denmark, Ambu A/S is a global medical technology company specializing in the design, manufacture, and sale of advanced medical devices. The company serves hospitals, clinics, and emergency services worldwide, providing essential healthcare solutions across key disciplines such as visualization, anesthesia, and patient monitoring and diagnostics. Their extensive product portfolio includes sophisticated endoscopy equipment like bronchoscopes and dedicated monitors. For neurology, Ambu offers EEG and EMG electrodes, as well as tools for EMG-guided injections and intraoperative monitoring systems. Cardiology solutions feature ECG electrodes. A substantial portion of their offerings is dedicated to airway management and anesthesia, comprising specialized bronchoscopes, video laryngoscopes, various intubation tubes (double and single lumen), endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitation devices. Additionally, Ambu provides critical emergency and training products, including extrication collars, CPR breathing barriers, and training manikins.
Prezzo delle azioni
$12.23
Capitalizzazione di mercato
$2.84B
Variazione (1 giorno)
1.99%
Variazione (1 anno)
-24.99%
Paese
DK
Scambia Ambu A/S (AMBU-B)

Categoria

Healthcare
Utile per Ambu A/S (AMBU-B)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Ambu A/S, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Ambu A/S dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
$7.51B -
US
$5.56B -
IE
$5.15B -
US
$3.86B -
US
- -
DE